Medingo milestones

1
Medingo milestones

• Solo MicroPump at the AADE 8-2009
• Medingo received formal clearance from
  FDA 7-2009?
• Elron will invest up to 22 Million in
  Medingo 11-2007
• Elron and Radius Ventures made the
  investment 11-2007

2
Solo MicroPump at the AADE

• Update Medingo will be unveiling the Solo
  MicroPump at the AADE meeting in early August.
  They also plan to launch their Solo website at
  that time. According to Craig Crease, Medingo's
  Director of Sales, they want to hold off on other
  information to "create an element of surprise".
  As I learn more I'll post it here.?
• http//www.bernardfarrell.com/blog/2009/07/medingo
  -solo-micropump-approved-by-fda.htm?

3
Medingo FDA

• Elron Electronic Industries Ltd. (NASDAQ TASE
  ELRN) announced, that further to it previous
  announcement on July 28, 2009, Medingo Ltd., a
  group company held 92 by Elron and its
  subsidiary, RDC - Rafael Development Corporation
  Ltd., has received formal clearance from the Food
  and Drug Administration ("FDA"), to market its
  Solo MicroPump Insulin Delivery System in the
  United States. Medingo intends to introduce the
  Solo MicroPump at the American Association of
  Diabetes Educators Meeting which will take place
  in August 2009 in Atlanta, U.S.A. "We are very
  excited to have received FDA clearance for
  Medingo's innovative, miniature, tube-free,
  insulin delivery system," commented Arie
  Mientkavich, Chairman of Medingo and Elron. "This
  is a major milestone for Medingo, which will
  enable it to progress to the next phase in its
  development. Medingo is currently considering
  alternatives for its go-to-market strategy and
  the timing of the product launch."?

4
Medingo investment 27M?

• TEL AVIV, Israel -- Elron Electronic Industries
  Ltd. (TASE NASDAQ ELRN), announced today that
  its group company, Medingo Ltd., wholly owned by
  its subsidiary, RDC Rafael Development
  Corporation Ltd. ("RDC"), has completed a
  financing round of approximately 27 million,
  jointly led by Elron, which will invest between
  13 million and 22 million (including 4 million
  of convertible loans) and Radius Ventures, a U.S.
  venture capital fund, which will invest 5
  million. Medingo is developing solutions
  specifically for the needs of insulin-dependent
  diabetic patients. Medingo's device is a
  miniature dispensing patch, which is convenient,
  easy to use, discreet and more cost-effective
  than standard insulin pumps. Medingo is in
  advanced stages of the development of this
  device, and it expects to receive FDA approval
  and to commence sales in 2008. Following the
  transaction, Elron will hold, directly and
  indirectly through RDC between 49 and 62 of
  Medingo's outstanding shares, depending on the
  amount of its investment.?
• http//findarticles.com/p/articles/mi_m0EIN/is_200
  7_Nov_20/ai_n27451451/

5
Elron and Radius Ventures made the investment
27M?

• Elron and Radius Ventures made the
  investment.Medical device start-up Medingo Ltd.
  has raised 27 million from its parent company,
  Elron Electronic Industries Ltd. (Nasdaq ELRN
  TASE ELRN) and US venture capital fund Radius
  Ventures. Elron will invest between 13 million
  and 22 million, including 4 million of
  convertible loans, and Radius Ventures will
  invest 5 million. Elron owns Medingo through
  Rafael Development Corporation. Medingo is
  developing a miniature dispensing patch for
  insulin-dependent diabetic patients. The device
  is a convenient, easy to use, discreet, and more
  cost-effective than standard insulin pumps.
  Medingo expects to obtain US Food and Drug
  Administration (FDA) approval for the patch and
  begin in 2008.?
• http//www.ivc-online.com/ivcWeeklyItem.asp?articl
  eID6240?